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Background: Down syndrome (DS) originates from having three 
copies of chromosome 21 (i.e. Trisomy 21). DS is associated with 
many detrimental phenotypes including intellectual disabilities, heart 
defects, abnormal craniofacial development, and obstructive sleep 
apnea, which develops from restricted nasopharyngeal airways and an 
underdeveloped mandible. Ts65Dn mice are trisomic for about half of 
the orthologs on human chromosome 21 and display many 
phenotypes associated with DS including craniofacial abnormalities. 
Dyrk1a is found in three copies in Ts65Dn mice and individuals with 
DS, and thought to be a root cause of the craniofacial phenotypes. 
Epigallocatechin 3-gallate (EGCG) is a green tea polyphenol and 
inhibitor of Dyrk1a activity.  
Purpose: We hypothesize that decreased Dyrk1a activity in Ts65Dn 
mice will ameliorate craniofacial dysmorphology.  
Methods: To test our hypothesis we compared Ts65Dn mice with two 
or three copies of Dyrk1a and compared Ts65Dn mice with and without 
prenatal EGCG treatment. EGCG treated mothers were fed 200mg/kg 
EGCG on gestational day 7. Six week old mice were sacrificed and 
their heads imaged using micro-computed tomography (µCT). From 
µCT images, we measured nasopharyngeal airway volume and 
anatomical landmarks (n = 54) from the facial skeleton, cranial vault, 
cranial base, and mandible. Mean nasopharyngeal airway volumes 
were graphically compared, and a landmark-based multivariate 
geometric morphometric approach known as Euclidean Distance 
Matrix Analysis (EDMA) was carried out to assess local differences in 
craniofacial morphology between trisomic mouse samples.  
Results: Our preliminary results indicate that EGCG treatment and 
reduced Dyrk1a copy number increases mean nasopharyngeal airway 
volume in Ts65Dn mice. Craniofacial morphometric differences were 
found among all samples. EGCG treatment increased portions of the 
mandible and decreased portions of the cranial vault and cranial base. 
Conclusion: Preliminary analyses suggest that both EGCG treatment 
and reduced Dyrk1a copy number affect craniofacial morphology.  
Down Syndrome (DS) is a relatively common genetic disorder found in 
1 in 700 live births. DS is caused by trisomy 21. DS is associated with 
craniofacial abnormalities and airway complications such as 
obstructive sleep apnea. Dyrk1a is a gene found in three copies in DS. 
The purpose of this preliminary study is to determine whether  
reducing copy number or activity of trisomic Dyrk1a will improve 
craniofacial phenotypes. We have done this by treating DS mice with 
Epigallocatechin 3-gallate (EGCG), a Dyrk1a inhibitor (n=4) or 
reducing Dyrk1a copy number in Ts65Dn mice (n=3) and comparing 
controls (n=4).  
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Left: Boundaries demarcated on 
µCT slices to measure 
nasopharyngeal airway volume. 
Top – sagittal plane, left –axial 
plane, right – coronal plane.  
Right: Anatomical landmarks 
measured from mouse skulls. 
Landmarks identified for the face 
are colored yellow, cranial vault in 
red, cranial base in blue, and 
mandible in green. 
Left: Superior and  lateral 3D reconstructions of nasopharyngeal airway volumes (pink). Left image is Ts65Dn+H2O. Middle image is Ts65Dn+EGCG. Right 
image is Ts65Dn/Dyrk1a+/-. 
Right: Comparison of Ts65Dn+H20, Ts65Dn+EGCG, and Ts65Dn/Dyrk1a+/- mean nasopharyngeal airway volume. Ts65Dn+EGCG mice exhibit increased 
nasopharyngeal airway volume relative to Ts65Dn+H20 mice. Ts65Dn/Dyrk1a+/- mice show increased nasopharyngeal airway volume relative to both 
Ts65Dn+H20 and Ts65Dn+EGCG mice.  
Two-sample morphometric analyses were carried out to compare mouse cohorts: 1) Ts65Dn+H20 compared to Ts65Dn+EGCG (blue); 2) Ts65Dn+EGCG 
compared to Ts65Dn/Dyrk1a+/- (red); and 3) Ts65Dn+H20 compared to Ts65Dn/Dyrk1a+/- (green).   
Left: Linear distances that significantly differ between 2-sample comparisons of mouse cohorts. 
Right: Percent of significantly different linear distances by craniofacial region for each 2-sample comparison. 
• EGCG treated mice exhibit increased nasopharyngeal airway volumes
relative to mice treated with H2O
• Ts65Dn/Dyrk1a+/- mice have increased nasopharyngeal airway
volumes relative to both H20 and EGCG treated mice.
• H20 treated mice and Ts65Dn/Dyrk1a+/- mice exhibit the most
morphological differences (as expected).
• EGCG treated mice are morphologically different from both H20 control
and Ts65Dn/Dyrk1a+/- mice, and exhibit a craniofacial form that is in
between the extreme morphological forms defined by H20 and
Ts65Dn/Dyrk1a+/- mice, which suggests that EGCG does influence
morphogenesis.
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EGCG treated mothers were fed 200mg/kg EGCG on gestational 
day 7.  Six week old mice were sacrificed and their heads imaged 
using micro-computed tomography (µCT; GE Healthcare, Inc. USA, 
EVS-R9 µCT scanner, tube voltage 50kVP, current 1000mA, shutter 
speed 400ms, 0.043mm resolution/voxel size).  Dolphin software 
(v11.5; Chatsworth, CA) was used to measure nasopharyngeal 
airway volumes and collect 3D coordinate values of anatomical 
landmarks (n = 54) from mouse skulls and mandibles. Mean 
nasopharyngeal airway volumes were compared among 3 samples: 
1) Ts65Dn mice with 3 copies of Dyrk1a treated with H20
(Ts65Dn+H20); 2) Ts65Dn mice with 3 copies of Dyrk1a treated with 
EGCG (Ts65Dn+EGCG); and 3) Ts65Dn knockout mice with 2 
copies of  Dyrk1a (Ts65Dn/Dyrk1a+/-). A multivariate geometric 
morphometric landmark-based approach known as Euclidean 
Distance Matrix Analysis (EDMA) was carried out to assess local 2-
sample morphological form differences among the 3 groups (see 
figure below). 
